NCT03827720View on ClinicalTrials.gov

Early Feasibility Study of the SENSE Device

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 6, 2019

Primary Completion Date

November 19, 2020

Study Completion Date

January 4, 2021

Conditions
Hemorrhagic StrokeIschemic Stroke
Interventions
DEVICE

SENSE Device

Non-invasive radiofrequency (RF) sensor

Trial Locations (2)

45212

TriHealth Hatton Research Institute - Good Samaritan Hospital, Cincinnati

45219

UC Health, Cincinnati

All Listed Sponsors
lead

Sense Diagnostics, LLC

INDUSTRY

NCT03827720 - Early Feasibility Study of the SENSE Device | Biotech Hunter | Biotech Hunter